DCT

1:15-cv-00404

In Re Bendamustine Consolidated Cases II

General
Filed
05/19/15
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (03/08/16)
Patent Owner
NPE (W)
Judge
Period
PO Win Rate
--
45%